{"id":88842,"date":"2024-07-25T11:41:38","date_gmt":"2024-07-25T09:41:38","guid":{"rendered":"https:\/\/www.anderapartners.com\/?p=88842"},"modified":"2024-07-25T11:45:24","modified_gmt":"2024-07-25T09:45:24","slug":"andera-partners-portfolio-company-jenavalve-technology-acquired-by-edwards-lifesciences","status":"publish","type":"post","link":"https:\/\/www.anderapartners.com\/en\/andera-partners-portfolio-company-jenavalve-technology-acquired-by-edwards-lifesciences\/","title":{"rendered":"Andera Partners\u2019 portfolio company JenaValve Technology acquired by Edwards Lifesciences"},"content":{"rendered":"<p><span data-contrast=\"auto\">Andera Partners, a leading European private <\/span><span data-contrast=\"auto\">equity player, announced today that its portfolio company, <\/span><span data-contrast=\"auto\">JenaValve <\/span><span data-contrast=\"auto\">Technology, a pioneer in the transcatheter treatment of aortic regurgitation (AR), will be acquired by Edwards Lifesciences, a leading medical technology company specializing in the development and manufacturing of products for the treatment of heart diseases and a pioneer in valve innovation for more than 60 years. This acquisition represents a significant milestone for Andera Partners, showcasing the firm\u2019s <\/span><span data-contrast=\"auto\">successful and flexible investment strategy.<\/span><b><span data-contrast=\"auto\">\u00a0<\/span><\/b><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\"><strong>Olivier Litzka, Partner at Andera Partners in Munich, and member of JenaValve&#8217;s advisory board since the company\u2019s inception,<\/strong> commented, <\/span><i><span data-contrast=\"auto\">&#8220;We are very happy to announce this important medtech transaction for Andera Partners, which marks the culmination of our dedicated support and strategic vision for JenaValve, completing a long and finally successful journey with the JenaValve team and the syndicate of great investor colleagues. Since our first investment in the Series A round, Andera Partners has continuously supported the company from its early days in Munich and later through its strategic move to Irvine, California. This time also encompasses JenaValve&#8217;s first phase of developing and commercializing a trans-apical TAVI device, later switching successfully to a transfemoral valve, and focusing on aortic regurgitation.\u201d<\/span><\/i><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">JenaValve Technology has made groundbreaking advances in the transcatheter treatment of aortic regurgitation, a severe and currently untreated condition affecting a growing population. With positive results from its U.S. pivotal trial for treating symptomatic, severe AR in high-risk patients, the company is on track for U.S. FDA approval of the JenaValve Trilogy Heart Valve System by late 2025.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><i><span data-contrast=\"auto\">\u201cJenaValve\u2019s success today is the result of overcoming development challenges inherent to highly innovative devices, then achieving CE mark approval, and most recently, publishing outstanding clinical data demonstrating best-in-class positioning of its valve. It is a great transition to see today\u2019s acquisition of JenaValve by Edwards Lifesciences<\/span><\/i> <i><span data-contrast=\"auto\">that is uniquely positioned to lead this next frontier of aortic valve disease treatment and will be able to bring the Trilogy valve effectively and globally to patients with AR. We want to thank the whole JenaValve team, the colleagues on the board, and in particular the many engaged doctors for their continued hard work, energy, and support for the company,\u201d<\/span><\/i><strong> Litzka added.<\/strong><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Andera Partners Life Sciences pursues a targeted investment strategy in Europe and in the US, with a focus on groundbreaking therapeutic products and innovative medical technologies. The broad investment spectrum ranges from start-ups and early-stage companies to growth and late-stage investment opportunities. Besides other areas like neurostimulation or robotics, one of the several key areas of interest and expertise for Andera Partners is the cardiovascular sector, both in drugs and devices, ranging from electrophysiology and hypertension to heart failure. <\/span><span data-contrast=\"auto\">It is with JenaValve and similar companies that the firm grew its expertise in the cardiovascular device market, <\/span><span data-contrast=\"auto\">followed by other significant investments in this thriving field. In structural heart diseases, besides JenaValve in aortic valve diseases, Andera Partners invested into the French-US mitral valve company HighLife and French-German tricuspid valve company TRiCares, positioning Andera at the forefront of heart valve technology.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Edwards Lifesciences <\/span><span data-contrast=\"auto\">communicated that the investment would strengthen its leadership in structural heart innovation and represent long-term growth opportunities. Edwards expects minimal revenue contribution from the acquisition in 2025. The acquisition is subject to the satisfaction of certain closing conditions, including the receipt of required antitrust and foreign investment approvals.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Andera Partners, a leading European private equity player, announced today that its portfolio company, JenaValve Technology, a pioneer in the transcatheter treatment of aortic regurgitation (AR), will be acquired by Edwards Lifesciences, a leading medical technology company specializing in the development and manufacturing of products for the treatment of heart diseases and a pioneer in&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[123],"class_list":["post-88842","post","type-post","status-publish","format-standard","hentry","category-biodiscovery-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Andera Partners\u2019 portfolio company JenaValve Technology acquired by Edwards Lifesciences - ANDERA PARTNERS<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.anderapartners.com\/en\/andera-partners-portfolio-company-jenavalve-technology-acquired-by-edwards-lifesciences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Andera Partners\u2019 portfolio company JenaValve Technology acquired by Edwards Lifesciences - ANDERA PARTNERS\" \/>\n<meta property=\"og:description\" content=\"Andera Partners, a leading European private equity player, announced today that its portfolio company, JenaValve Technology, a pioneer in the transcatheter treatment of aortic regurgitation (AR), will be acquired by Edwards Lifesciences, a leading medical technology company specializing in the development and manufacturing of products for the treatment of heart diseases and a pioneer in...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.anderapartners.com\/en\/andera-partners-portfolio-company-jenavalve-technology-acquired-by-edwards-lifesciences\/\" \/>\n<meta property=\"og:site_name\" content=\"ANDERA PARTNERS\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-25T09:41:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-25T09:45:24+00:00\" \/>\n<meta name=\"author\" content=\"Nicolas Delsert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nicolas Delsert\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.anderapartners.com\/en\/andera-partners-portfolio-company-jenavalve-technology-acquired-by-edwards-lifesciences\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.anderapartners.com\/en\/andera-partners-portfolio-company-jenavalve-technology-acquired-by-edwards-lifesciences\/\"},\"author\":{\"name\":\"Nicolas Delsert\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c\"},\"headline\":\"Andera Partners\u2019 portfolio company JenaValve Technology acquired by Edwards Lifesciences\",\"datePublished\":\"2024-07-25T09:41:38+00:00\",\"dateModified\":\"2024-07-25T09:45:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.anderapartners.com\/en\/andera-partners-portfolio-company-jenavalve-technology-acquired-by-edwards-lifesciences\/\"},\"wordCount\":574,\"publisher\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\"},\"articleSection\":[\"andera Life Sciences\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.anderapartners.com\/en\/andera-partners-portfolio-company-jenavalve-technology-acquired-by-edwards-lifesciences\/\",\"url\":\"https:\/\/www.anderapartners.com\/en\/andera-partners-portfolio-company-jenavalve-technology-acquired-by-edwards-lifesciences\/\",\"name\":\"Andera Partners\u2019 portfolio company JenaValve Technology acquired by Edwards Lifesciences - ANDERA PARTNERS\",\"isPartOf\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#website\"},\"datePublished\":\"2024-07-25T09:41:38+00:00\",\"dateModified\":\"2024-07-25T09:45:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.anderapartners.com\/en\/andera-partners-portfolio-company-jenavalve-technology-acquired-by-edwards-lifesciences\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.anderapartners.com\/en\/andera-partners-portfolio-company-jenavalve-technology-acquired-by-edwards-lifesciences\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.anderapartners.com\/en\/andera-partners-portfolio-company-jenavalve-technology-acquired-by-edwards-lifesciences\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.anderapartners.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Andera Partners\u2019 portfolio company JenaValve Technology acquired by Edwards Lifesciences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#website\",\"url\":\"https:\/\/www.anderapartners.com\/fr\/\",\"name\":\"ANDERA PARTNERS\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.anderapartners.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\",\"name\":\"Andera Partners\",\"url\":\"https:\/\/www.anderapartners.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg\",\"contentUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg\",\"width\":107,\"height\":44,\"caption\":\"Andera Partners\"},\"image\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c\",\"name\":\"Nicolas Delsert\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g\",\"caption\":\"Nicolas Delsert\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Andera Partners\u2019 portfolio company JenaValve Technology acquired by Edwards Lifesciences - ANDERA PARTNERS","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.anderapartners.com\/en\/andera-partners-portfolio-company-jenavalve-technology-acquired-by-edwards-lifesciences\/","og_locale":"en_US","og_type":"article","og_title":"Andera Partners\u2019 portfolio company JenaValve Technology acquired by Edwards Lifesciences - ANDERA PARTNERS","og_description":"Andera Partners, a leading European private equity player, announced today that its portfolio company, JenaValve Technology, a pioneer in the transcatheter treatment of aortic regurgitation (AR), will be acquired by Edwards Lifesciences, a leading medical technology company specializing in the development and manufacturing of products for the treatment of heart diseases and a pioneer in...","og_url":"https:\/\/www.anderapartners.com\/en\/andera-partners-portfolio-company-jenavalve-technology-acquired-by-edwards-lifesciences\/","og_site_name":"ANDERA PARTNERS","article_published_time":"2024-07-25T09:41:38+00:00","article_modified_time":"2024-07-25T09:45:24+00:00","author":"Nicolas Delsert","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Nicolas Delsert","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.anderapartners.com\/en\/andera-partners-portfolio-company-jenavalve-technology-acquired-by-edwards-lifesciences\/#article","isPartOf":{"@id":"https:\/\/www.anderapartners.com\/en\/andera-partners-portfolio-company-jenavalve-technology-acquired-by-edwards-lifesciences\/"},"author":{"name":"Nicolas Delsert","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c"},"headline":"Andera Partners\u2019 portfolio company JenaValve Technology acquired by Edwards Lifesciences","datePublished":"2024-07-25T09:41:38+00:00","dateModified":"2024-07-25T09:45:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.anderapartners.com\/en\/andera-partners-portfolio-company-jenavalve-technology-acquired-by-edwards-lifesciences\/"},"wordCount":574,"publisher":{"@id":"https:\/\/www.anderapartners.com\/fr\/#organization"},"articleSection":["andera Life Sciences"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.anderapartners.com\/en\/andera-partners-portfolio-company-jenavalve-technology-acquired-by-edwards-lifesciences\/","url":"https:\/\/www.anderapartners.com\/en\/andera-partners-portfolio-company-jenavalve-technology-acquired-by-edwards-lifesciences\/","name":"Andera Partners\u2019 portfolio company JenaValve Technology acquired by Edwards Lifesciences - ANDERA PARTNERS","isPartOf":{"@id":"https:\/\/www.anderapartners.com\/fr\/#website"},"datePublished":"2024-07-25T09:41:38+00:00","dateModified":"2024-07-25T09:45:24+00:00","breadcrumb":{"@id":"https:\/\/www.anderapartners.com\/en\/andera-partners-portfolio-company-jenavalve-technology-acquired-by-edwards-lifesciences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.anderapartners.com\/en\/andera-partners-portfolio-company-jenavalve-technology-acquired-by-edwards-lifesciences\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.anderapartners.com\/en\/andera-partners-portfolio-company-jenavalve-technology-acquired-by-edwards-lifesciences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.anderapartners.com\/en\/"},{"@type":"ListItem","position":2,"name":"Andera Partners\u2019 portfolio company JenaValve Technology acquired by Edwards Lifesciences"}]},{"@type":"WebSite","@id":"https:\/\/www.anderapartners.com\/fr\/#website","url":"https:\/\/www.anderapartners.com\/fr\/","name":"ANDERA PARTNERS","description":"","publisher":{"@id":"https:\/\/www.anderapartners.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.anderapartners.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.anderapartners.com\/fr\/#organization","name":"Andera Partners","url":"https:\/\/www.anderapartners.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg","contentUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg","width":107,"height":44,"caption":"Andera Partners"},"image":{"@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c","name":"Nicolas Delsert","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g","caption":"Nicolas Delsert"}}]}},"_links":{"self":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/posts\/88842","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/comments?post=88842"}],"version-history":[{"count":1,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/posts\/88842\/revisions"}],"predecessor-version":[{"id":88843,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/posts\/88842\/revisions\/88843"}],"wp:attachment":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/media?parent=88842"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/categories?post=88842"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}